Mortality, Stroke, and Hospitalization Associated With Deferred vs Expedited Aortic Valve Replacement in Patients Referred for Symptomatic Severe Aortic Stenosis During the COVID-19 Pandemic

Christoph Ryffel; Jonas Lanz; Noé Corpataux; Nicole Reusser; Stefan Stortecky; Stephan Windecker; Thomas Pilgrim

doi:10.1001/jamanetworkopen.2020.20402

Mortality, Stroke, and Hospitalization Associated With Deferred vs Expedited Aortic Valve Replacement in Patients Referred for Symptomatic Severe Aortic Stenosis During the COVID-19 Pandemic

JAMA Netw Open. 2020 Sep 1;3(9):e2020402. doi: 10.1001/jamanetworkopen.2020.20402.

Authors

Christoph Ryffel¹, Jonas Lanz¹, Noé Corpataux¹, Nicole Reusser¹, Stefan Stortecky¹, Stephan Windecker¹, Thomas Pilgrim¹

Affiliation

¹ Department of Cardiology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.

Abstract

This cohort study evaluates the outcomes associated with deferred vs expedited aortic valve replacement in patients with severe aortic stenosis during the COVID-19 pandemic.

MeSH terms

Aged
Aged, 80 and over
Aortic Valve Stenosis / mortality
Aortic Valve Stenosis / surgery*
COVID-19
Case-Control Studies
Coronavirus Infections
Female
Hospitalization / statistics & numerical data*
Humans
Kaplan-Meier Estimate
Male
Pandemics
Pneumonia, Viral
Referral and Consultation
Severity of Illness Index
Stroke / epidemiology*
Time-to-Treatment / statistics & numerical data*
Transcatheter Aortic Valve Replacement*